X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor

J Med Chem. 2001 Mar 1;44(5):660-3. doi: 10.1021/jm0002681.
No abstract available

MeSH terms

  • Animals
  • Benzamides / chemical synthesis*
  • Benzamides / chemistry
  • Benzamides / pharmacology
  • Bone Resorption / drug therapy
  • Bone and Bones / enzymology*
  • Citric Acid / chemistry*
  • Crystallography, X-Ray
  • Cyclohexanes / chemical synthesis*
  • Cyclohexanes / chemistry
  • Cyclohexanes / pharmacology
  • Durapatite / chemistry
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Ligands
  • Models, Molecular
  • Molecular Mimicry
  • Organophosphorus Compounds / chemical synthesis*
  • Organophosphorus Compounds / chemistry
  • Organophosphorus Compounds / pharmacology
  • Osteoclasts / pathology
  • Phosphotyrosine / chemistry
  • Protein Binding
  • Proto-Oncogene Proteins pp60(c-src) / antagonists & inhibitors
  • Proto-Oncogene Proteins pp60(c-src) / chemistry*
  • Rabbits
  • src Homology Domains*

Substances

  • Benzamides
  • Cyclohexanes
  • Enzyme Inhibitors
  • Ligands
  • Organophosphorus Compounds
  • Phosphotyrosine
  • Citric Acid
  • Durapatite
  • Proto-Oncogene Proteins pp60(c-src)